Relationship between 1-year change in the bone turnover marker P1NP and 3-year vertebral fracture risk reduction with raloxifene therapy in postmenopausal women with osteoporosis: Results from the MORE trial

被引：0
|
作者：
Reginster, JY
Sarkar, S
Collette, J
Zegels, B
Henrotin, Y
Bruyere, O
Wong, M
Harper, K
Agnusdei, D
机构：
[1] CHU Ctr Ville, Liege, Belgium
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Eli Lilly Italia, Florence, Italy
来源：
BONE | 2001年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 39 条
  • [1] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial
    Ettinger, B
    Black, DM
    Mitlak, BH
    Knickerbocker, RK
    Nickelsen, T
    Genant, HK
    Christiansen, C
    Delmas, PD
    Zanchetta, JR
    Stakkestad, J
    Glüer, CC
    Krueger, K
    Cohen, FJ
    Eckert, S
    Ensrud, KE
    Avioli, LV
    Lips, P
    Cummings, SR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07): : 637 - 645
  • [2] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial (vol 282, pg 637, 1999)
    Ettinger, B
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (22): : 2124 - 2124
  • [3] Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
    Delmas, PD
    Ensrud, KE
    Adachi, JD
    Harper, KD
    Sarkar, S
    Gennari, C
    Reginster, JY
    Pols, HAP
    Recker, RR
    Harris, ST
    Wu, WT
    Genant, HK
    Black, DM
    Eastell, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08): : 3609 - 3617
  • [4] The effect of raloxifene on cardiovascular risk in osteoporotic postmenopausal women: 3-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) trial.
    Harper, KD
    Barrett-Connor, E
    Sashegyi, A
    Sarkar, S
    Krueger, KA
    Cox, DA
    Anderson, PW
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S5 - S6
  • [5] The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis: 4-year results from the MORE Trial.
    Eastell, R
    Adachi, J
    Harper, K
    Sarkar, S
    Delmas, PD
    Ensrud, K
    Gennari, C
    Reginster, JY
    Pols, H
    Recker, R
    Harris, S
    Wu, W
    Genant, H
    Black, D
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S229 - S229
  • [6] The association between changes in bone mineral density (BMD) and biochemical markers of bone turnover at 1 year with vertebral fracture risk at 3 years: Results from the multiple outcomes of raloxifene evaluation (MORE) trial
    Sarkar, S
    Crans, GG
    Wong, M
    Harper, KD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S208 - S208
  • [7] Effects of Raloxifene on bone mineral density and biochemical markers of bone turnover in postmenopausal women with osteoporosis: 4-Year results from the MORE trial.
    Delmas, PD
    Ensrud, KE
    Harper, K
    Wu, W
    Adachi, J
    Easteil, R
    Gennari, C
    Reginster, JY
    Pols, H
    Recker, R
    Bjarnason, N
    Sarkar, S
    Black, D
    Genant, H
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S556 - S556
  • [8] Relationships between age and prior use of HRT on vertebral fracture risk reduction with raloxifene in postmenopausal women: Results from the MORE trial.
    Johnell, O
    Kanis, JA
    Sarkar, S
    Wu, W
    de Laet, C
    Oden, A
    Pavo, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S414 - S414
  • [9] Prevalent vertebral fracture severity predicts subsequent vertebral and nonvertebral fracture risk in postmenopausal women with osteoporosis: Results from the multiple outcomes of raloxifene evaluation (MORE) trial
    Delmas, P
    Genant, H
    Crans, G
    Siris, E
    Wong, M
    Sarkar, S
    Stock, J
    Harper, K
    Adachi, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) : 521 - 521
  • [10] Prevalent vertebral fracture severity predicts subsequent vertebral and nonvertebral fracture risk in postmenopausal women with osteoporosis: Results from the multiple outcomes of raloxifene evaluation (more) trial
    Delmas, P
    Genant, H
    Crans, G
    Siris, E
    Wong, M
    Sarkar, S
    Stock, J
    Harper, K
    Adachi, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13
1234